Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Shree Sharma

Concepts (117)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Renal Cell
2
2010
112
0.590
Why?
Kidney Neoplasms
2
2010
181
0.560
Why?
Glomerulonephritis, Membranous
3
2020
28
0.470
Why?
Diabetic Nephropathies
1
2013
61
0.380
Why?
Kidney
2
2013
717
0.340
Why?
Angiogenesis Inducing Agents
1
2010
8
0.330
Why?
Glomerulonephritis, IGA
1
2010
6
0.330
Why?
PAX2 Transcription Factor
1
2010
24
0.320
Why?
Podocytes
1
2010
22
0.320
Why?
Carcinoma, Papillary
1
2010
50
0.320
Why?
Neovascularization, Physiologic
1
2010
86
0.310
Why?
Proto-Oncogene Proteins B-raf
1
2010
78
0.310
Why?
Diabetes Mellitus
1
2013
321
0.300
Why?
Vascular Endothelial Growth Factor A
1
2010
189
0.290
Why?
Neovascularization, Pathologic
1
2010
158
0.290
Why?
Angiogenesis Inhibitors
1
2010
186
0.280
Why?
Immunohistochemistry
1
2010
975
0.270
Why?
Heart Diseases
1
2010
221
0.270
Why?
Colorectal Neoplasms
1
2010
302
0.240
Why?
Adenocarcinoma
1
2010
405
0.240
Why?
Kidney Diseases
2
2019
230
0.210
Why?
Lupus Nephritis
1
2020
18
0.160
Why?
Lupus Erythematosus, Systemic
1
2020
67
0.160
Why?
Biopsy
2
2013
600
0.160
Why?
Glomerulonephritis
1
2019
16
0.150
Why?
Humans
13
2020
53246
0.120
Why?
Proflavine
1
2015
1
0.110
Why?
Endothelin-1
1
2015
35
0.110
Why?
Fluorescent Dyes
1
2015
90
0.110
Why?
Point-of-Care Systems
1
2015
68
0.110
Why?
Phenazopyridine
1
2014
3
0.100
Why?
Nephritis, Interstitial
1
2014
9
0.100
Why?
Contrast Media
1
2015
178
0.100
Why?
Glomerular Filtration Rate
1
2013
128
0.100
Why?
Myocardium
1
2015
471
0.090
Why?
Vascular Endothelial Growth Factors
1
2010
15
0.080
Why?
Microscopy, Electron, Transmission
1
2010
68
0.080
Why?
Colonic Neoplasms
1
2012
162
0.080
Why?
Hematuria
1
2010
25
0.080
Why?
Proteinuria
1
2010
38
0.080
Why?
Fluorescent Antibody Technique
1
2010
109
0.080
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
1
2010
12
0.080
Why?
Fibroblast Growth Factors
1
2010
52
0.080
Why?
Neoplasms
1
2020
1335
0.080
Why?
Gene Expression Regulation
1
2015
1003
0.080
Why?
Von Hippel-Lindau Tumor Suppressor Protein
1
2010
7
0.080
Why?
Neoplasm Metastasis
1
2010
237
0.080
Why?
Patents as Topic
1
2010
10
0.080
Why?
DNA Mutational Analysis
1
2010
179
0.080
Why?
DNA, Neoplasm
1
2010
146
0.080
Why?
Cell Nucleus
1
2010
187
0.080
Why?
Integrins
1
2010
34
0.080
Why?
Female
5
2019
28792
0.080
Why?
Renal Insufficiency
1
2010
108
0.080
Why?
Matrix Metalloproteinases
1
2010
47
0.080
Why?
Amlodipine
1
2009
14
0.080
Why?
Aging
1
2015
715
0.080
Why?
Fluorobenzenes
1
2009
21
0.080
Why?
Genetic Therapy
1
2010
127
0.080
Why?
Stem Cell Transplantation
1
2010
191
0.070
Why?
TOR Serine-Threonine Kinases
1
2010
83
0.070
Why?
Immunoglobulin G
2
2020
192
0.070
Why?
Hypercholesterolemia
1
2009
40
0.070
Why?
Calcium Channel Blockers
1
2009
57
0.070
Why?
Cardiomegaly
1
2009
55
0.070
Why?
Intracellular Signaling Peptides and Proteins
1
2010
136
0.070
Why?
Male
6
2020
27444
0.070
Why?
Sensitivity and Specificity
1
2010
869
0.070
Why?
Sulfonamides
1
2009
139
0.070
Why?
Nanoparticles
1
2010
133
0.070
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2009
146
0.070
Why?
Pyrimidines
1
2009
206
0.070
Why?
Drug Delivery Systems
1
2010
148
0.070
Why?
Predictive Value of Tests
1
2010
933
0.070
Why?
Diagnosis, Differential
1
2010
1038
0.060
Why?
Aged
3
2020
10430
0.060
Why?
Models, Biological
1
2010
737
0.060
Why?
Antibodies, Monoclonal
1
2010
477
0.060
Why?
Retrospective Studies
1
2013
6821
0.040
Why?
Middle Aged
2
2013
13422
0.040
Why?
Neural Cell Adhesion Molecules
1
2020
10
0.040
Why?
Receptors, Phospholipase A2
1
2020
14
0.040
Why?
Thrombospondins
1
2020
10
0.040
Why?
Autoantigens
1
2020
46
0.040
Why?
Calcium-Binding Proteins
1
2020
58
0.040
Why?
Autoantibodies
1
2020
120
0.040
Why?
Kidney Glomerulus
1
2019
43
0.040
Why?
Multiple Myeloma
1
2012
3082
0.030
Why?
Aspartic Acid Endopeptidases
1
2015
17
0.030
Why?
beta-Galactosidase
1
2015
32
0.030
Why?
Microscopy, Fluorescence
1
2015
140
0.030
Why?
Gene Knockdown Techniques
1
2015
109
0.030
Why?
Metalloendopeptidases
1
2015
70
0.030
Why?
Estrogen Receptor alpha
1
2015
85
0.030
Why?
Enzyme Activation
1
2015
267
0.030
Why?
RNA Interference
1
2015
181
0.030
Why?
Fibrosis
1
2015
198
0.030
Why?
Up-Regulation
1
2015
456
0.020
Why?
Fibroblasts
1
2015
363
0.020
Why?
Mice
2
2015
5982
0.020
Why?
Fatal Outcome
1
2012
193
0.020
Why?
Cell Line, Tumor
1
2015
1470
0.020
Why?
Cholesterol, Dietary
1
2009
19
0.020
Why?
Receptors, LDL
1
2009
73
0.020
Why?
Lipids
1
2009
163
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
579
0.020
Why?
Drug Therapy, Combination
1
2009
405
0.020
Why?
Signal Transduction
1
2015
1748
0.020
Why?
Body Weight
1
2009
524
0.020
Why?
Animals
2
2015
13528
0.020
Why?
Gene Expression
1
2009
618
0.020
Why?
Hematopoietic Stem Cell Transplantation
1
2012
610
0.020
Why?
Blood Pressure
1
2009
518
0.020
Why?
Mice, Knockout
1
2009
910
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2012
1043
0.010
Why?
Disease Models, Animal
1
2009
1517
0.010
Why?
Treatment Outcome
1
2009
5597
0.010
Why?
Sharma's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description